MP:0000313 | abnormal cell death | "anomalous cessation of function at the cellular level" [Stedman s Medical Dictionary:ISBN 0-683-40008-8] |
Show
Allelic Composition: Fdft1tm1Kan/Fdft1tm1Kan,Cnptm1(cre)Kan/Cnp+ Genetic Background: involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ
|
MP:0001051 | abnormal somatic motor system morphology | |
Show
Allelic Composition: Fdft1tm1Kan/Fdft1tm1Kan,Cnptm1(cre)Kan/Cnp+ Genetic Background: involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ
Allelic Composition: Mapk10tm1Flv/Mapk10tm1Flv,Mapk9tm1Flv/Mapk9tm1Flv Genetic Background: B6.129S-Mapk9tm1Flv Mapk10tm1Flv
|
MP:0001405 | impaired coordination | "reduced ability to execute integrated movements of muscle" [csmith:Cynthia L. Smith , Mouse Genome Informatics Curator, Stedman s Medical Dictionary , 27th edition:ISBN 0-683-40008-8] |
Show
Allelic Composition: Fdft1tm1Kan/Fdft1tm1Kan,Cnptm1(cre)Kan/Cnp+ Genetic Background: involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ
|
MP:0001905 | abnormal dopamine level | "greater or less than the normal concentration of this catecholamine neurotransmitter, dervied from tyrosine and the precursor to norepinephrine and epinephrine" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator, MeSH:National Library of Medicine - Medical Subject Headings , 2003] |
Show
Allelic Composition: Fdft1tm1Kan/Fdft1tm1Kan,Cnptm1(cre)Kan/Cnp+ Genetic Background: involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ
Allelic Composition: Mapk10tm1Flv/Mapk10tm1Flv,Mapk9tm1Flv/Mapk9tm1Flv Genetic Background: B6.129S-Mapk9tm1Flv Mapk10tm1Flv
|
MP:0002608 | increased hematocrit | "greater than average percentage of a volume of a blood sample occupied by red blood cells" [csmith:Cynthia L. Smith , Mouse Genome Informatics Curator, Stedman s Medical Dictionary , 27th edition:ISBN 0-683-40008-8] |
Show
Allelic Composition: Nbeal2tm1a(EUCOMM)Wtsi/Nbeal2tm1a(EUCOMM)Wtsi Genetic Background: C57BL/6N-Nbeal2tm1a(EUCOMM)Wtsi/Wtsi
|
MP:0002887 | resistance to pharmacologically induced seizures | "ability to withstand doses of pharmacological drugs that induce seizure activity in normal animals" [csmith:Cynthia L. Smith , Mouse Genome Informatics Curator, J:77284] |
Show
Allelic Composition: Fdft1tm1Kan/Fdft1tm1Kan,Cnptm1(cre)Kan/Cnp+ Genetic Background: involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ
|
MP:0003131 | increased erythrocyte count | "greater number of the cells in the blood that carry oxygen, red blood cells, per unit" [csmith:Cynthia L. Smith, Mouse Genome Informatics Curator] |
Show
Allelic Composition: Nbeal2tm1a(EUCOMM)Wtsi/Nbeal2tm1a(EUCOMM)Wtsi Genetic Background: C57BL/6N-Nbeal2tm1a(EUCOMM)Wtsi/Wtsi
|
MP:0003204 | decreased neuron apoptosis | "decrease in the number of neurons undergoing programmed cell death" [RGD:Rat Genome Database submission] |
Show
Allelic Composition: Fdft1tm1Kan/Fdft1tm1Kan,Cnptm1(cre)Kan/Cnp+ Genetic Background: involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ
|
MP:0008236 | decreased susceptibility to neuronal excitotoxicity | "less than normal amount of neuronal cell death following exposure to a neurotoxic compound, such as kaniate-induced neuronal cell death mediated via a glutamate excitotoxic process" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Fdft1tm1Kan/Fdft1tm1Kan,Cnptm1(cre)Kan/Cnp+ Genetic Background: involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ
|
MP:0011452 | decreased susceptibility to dopaminergic neuron neurotoxicity | "less than normal amount of dopaminergic neuronal cell death following exposure to a neurotoxic compound, such as MPTP-induced cell death occurring through interference in mitochondrial metabolism" [MGI:csmith] |
Show
Allelic Composition: Fdft1tm1Kan/Fdft1tm1Kan,Cnptm1(cre)Kan/Cnp+ Genetic Background: involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ
Allelic Composition: Mapk10tm1Flv/Mapk10tm1Flv,Mapk9tm1Flv/Mapk9tm1Flv Genetic Background: B6.129S-Mapk9tm1Flv Mapk10tm1Flv
|